SoylentNews is people
SoylentNews is powered by your submissions, so send in your scoop. Only 17 submissions in the queue.
SoylentNews
U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
This discussion has been archived.
No new comments can be posted.
U.S. Insulin Costs Nearly Doubled From 2012 to 2016
|
Log In/Create an Account
| Top
| 64 comments
| Search Discussion
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
The last time I saw him he was walking down Lover's Lane holding his own hand.
-- Fred Allen
(Score: 2) by Immerman on Wednesday January 23 2019, @03:33PM
That's the medical industry - the insurance industry is on the hook for a lot of that expense too, and is only interested in your survival if it means you can reasonably be expected to pay enough future premiums to cover their current expenses.